IRIS
COSSIGA, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.923
NA - Nord America 1.608
EU - Europa 1.095
SA - Sud America 272
AF - Africa 49
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.954
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.542
SG - Singapore 802
RU - Federazione Russa 572
CN - Cina 433
VN - Vietnam 352
BR - Brasile 227
IT - Italia 164
DE - Germania 101
HK - Hong Kong 101
FR - Francia 62
GB - Regno Unito 53
JP - Giappone 48
NL - Olanda 48
IN - India 39
KR - Corea 39
CA - Canada 34
BD - Bangladesh 27
CI - Costa d'Avorio 19
AR - Argentina 17
MX - Messico 16
FI - Finlandia 15
PL - Polonia 14
ZA - Sudafrica 14
UA - Ucraina 12
PH - Filippine 11
ES - Italia 10
IQ - Iraq 10
ID - Indonesia 9
TH - Thailandia 9
AT - Austria 8
EC - Ecuador 7
LT - Lituania 7
SE - Svezia 7
TR - Turchia 7
IE - Irlanda 6
VE - Venezuela 6
CL - Cile 5
HN - Honduras 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
PE - Perù 4
AM - Armenia 3
AZ - Azerbaigian 3
BE - Belgio 3
CO - Colombia 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
AU - Australia 2
CH - Svizzera 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
LV - Lettonia 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ML - Mali 1
MY - Malesia 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PF - Polinesia Francese 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
TN - Tunisia 1
ZM - Zambia 1
Totale 4.954
Salva come PNG Salva come JPEG
Città #
Singapore 437
San Jose 284
Hefei 192
Moscow 137
Ashburn 132
Ho Chi Minh City 102
Hong Kong 97
Beijing 94
Hanoi 69
Santa Clara 66
Lauterbourg 42
Tokyo 42
Chandler 41
Los Angeles 41
Amsterdam 38
Seoul 35
New York 34
Naples 32
The Dalles 31
Frankfurt am Main 22
Munich 22
Buffalo 21
Düsseldorf 20
São Paulo 20
Council Bluffs 19
Kochi 17
Da Nang 16
Dallas 16
Chicago 15
Redondo Beach 15
Atlanta 14
Orem 14
London 13
Millbury 13
Toronto 13
Haiphong 12
Warsaw 12
Helsinki 11
Mexico City 10
Milan 10
Poplar 10
Brooklyn 9
Lawrence 9
Nuremberg 9
Denver 8
Des Moines 8
Manchester 8
Can Tho 7
Jacksonville 7
Johannesburg 7
Montreal 7
Napoli 7
Rio de Janeiro 7
San Francisco 7
Stockholm 7
Turin 7
Bangkok 6
Biên Hòa 6
Boston 6
Falkenstein 6
Hải Dương 6
Phoenix 6
Porto Alegre 6
Vienna 6
Ankara 5
Chennai 5
Dublin 5
Ninh Bình 5
Portsmouth 5
Rome 5
Seattle 5
Afragola 4
Baghdad 4
Baronissi 4
Brasília 4
Dong Ket 4
Memphis 4
Mumbai 4
Newark 4
Philadelphia 4
Rochdale 4
Santa Maria La Carità 4
Thái Nguyên 4
Tân Tiến 4
Amman 3
Bologna 3
Brussels 3
Cairo 3
Caivano 3
Cape Town 3
Capodrise 3
Contagem 3
Curitiba 3
Guayaquil 3
Houston 3
Jeddah 3
Joinville 3
Jundiaí 3
Las Vegas 3
Legnaro 3
Totale 2.578
Salva come PNG Salva come JPEG
Nome #
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 440
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease 198
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 178
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 165
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 159
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 152
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 143
Pattern of macrovascular invasion in hepatocellular carcinoma 141
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 140
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 139
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 137
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 135
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 134
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 133
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 133
Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country 130
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 127
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 127
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 119
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 117
Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage 117
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 116
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 116
Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign 115
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 115
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 114
The interpretation of liver function tests in pregnancy 113
Safety and Immunogenicity of Anti-SARS-CoV-2 Booster Dose in Patients with Chronic Liver Disease 108
Impact of SARS-CoV-2 Pandemic on the Management of Patients with Hepatocellular Carcinoma 108
COVID-19 and Fatty Liver Disorders 103
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 102
Ribociclib in newly diagnosed hepatitis B infection: A case report 94
Prediction of Clinical Trajectory in HCV-Related ACLD after SVR: Role of Liver Stiffness in a 5-Years Prospective Study 94
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 91
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis 90
Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature 74
Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice 64
Vascular liver diseases: A sex-oriented analysis of the literature 61
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open! 60
Refined classification and phenotype-driven analysis of PIEZO1 variants in hereditary red cell and iron disorders 6
Uncovering hidden HCV infections in adults over 55: reflex testing and insights for opportunistic screening in a tertiary care setting 3
Totale 5.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 0 0 1 1 0 8 22 23
2022/2023130 9 2 4 6 25 11 6 2 10 40 12 3
2023/2024216 5 59 39 18 5 9 3 23 3 15 22 15
2024/20251.318 55 47 2 23 40 70 126 103 98 124 532 98
2025/20262.805 261 342 325 305 451 115 302 167 256 150 55 76
2026/2027428 428 0 0 0 0 0 0 0 0 0 0 0
Totale 5.011